• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度和冷却持续时间对患有缺氧缺血性脑病的新生儿重症监护病房死亡率的影响:一项随机临床试验。

Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial.

机构信息

Department of Pediatrics, Wayne State University, Detroit, Michigan.

Department of Pediatrics, Women and Infants Hospital, Brown University, Providence, Rhode Island.

出版信息

JAMA. 2014;312(24):2629-39. doi: 10.1001/jama.2014.16058.

DOI:10.1001/jama.2014.16058
PMID:25536254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4335311/
Abstract

IMPORTANCE

Hypothermia at 33.5°C for 72 hours for neonatal hypoxic ischemic encephalopathy reduces death or disability to 44% to 55%; longer cooling and deeper cooling are neuroprotective in animal models.

OBJECTIVE

To determine if longer duration cooling (120 hours), deeper cooling (32.0°C), or both are superior to cooling at 33.5°C for 72 hours in neonates who are full-term with moderate or severe hypoxic ischemic encephalopathy.

DESIGN, SETTING, AND PARTICIPANTS: A randomized, 2 × 2 factorial design clinical trial performed in 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network between October 2010 and November 2013.

INTERVENTIONS

Neonates were assigned to 4 hypothermia groups; 33.5°C for 72 hours, 32.0°C for 72 hours, 33.5°C for 120 hours, and 32.0°C for 120 hours.

MAIN OUTCOMES AND MEASURES

The primary outcome of death or disability at 18 to 22 months is ongoing. The independent data and safety monitoring committee paused the trial to evaluate safety (cardiac arrhythmia, persistent acidosis, major vessel thrombosis and bleeding, and death in the neonatal intensive care unit [NICU]) after the first 50 neonates were enrolled, then after every subsequent 25 neonates. The trial was closed for emerging safety profile and futility analysis after the eighth review with 364 neonates enrolled (of 726 planned). This report focuses on safety and NICU deaths by marginal comparisons of 72 hours' vs 120 hours' duration and 33.5°C depth vs 32.0°C depth (predefined secondary outcomes).

RESULTS

The NICU death rates were 7 of 95 neonates (7%) for the 33.5°C for 72 hours group, 13 of 90 neonates (14%) for the 32.0°C for 72 hours group, 15 of 96 neonates (16%) for the 33.5°C for 120 hours group, and 14 of 83 neonates (17%) for the 32.0°C for 120 hours group. The adjusted risk ratio (RR) for NICU deaths for the 120 hours group vs 72 hours group was 1.37 (95% CI, 0.92-2.04) and for the 32.0°C group vs 33.5°C group was 1.24 (95% CI, 0.69-2.25). Safety outcomes were similar between the 120 hours group vs 72 hours group and the 32.0°C group vs 33.5°C group, except major bleeding occurred among 1% in the 120 hours group vs 3% in the 72 hours group (RR, 0.25 [95% CI, 0.07-0.91]). Futility analysis determined that the probability of detecting a statistically significant benefit for longer cooling, deeper cooling, or both for NICU death was less than 2%.

CONCLUSIONS AND RELEVANCE

Among neonates who were full-term with moderate or severe hypoxic ischemic encephalopathy, longer cooling, deeper cooling, or both compared with hypothermia at 33.5°C for 72 hours did not reduce NICU death. These results have implications for patient care and design of future trials.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT01192776.

摘要

重要提示

对于患有缺氧缺血性脑病的足月新生儿,在 33.5°C 下进行 72 小时的低温治疗可将死亡或残疾率降低到 44%至 55%;在动物模型中,更长时间的冷却和更深的冷却具有神经保护作用。

目的

确定与 33.5°C 下 72 小时的冷却相比,更长时间(120 小时)、更深的冷却(32.0°C)或两者联合应用于中重度缺氧缺血性脑病的足月新生儿是否更优。

设计、地点和参与者:这是一项在美国国立卫生研究院儿童健康与人类发育研究所(NICHD)新生儿研究网络的 18 个中心进行的随机、2×2 析因设计临床试验,于 2010 年 10 月至 2013 年 11 月期间进行。

干预措施

新生儿被分配到 4 个低温治疗组:33.5°C 下 72 小时、32.0°C 下 72 小时、33.5°C 下 120 小时和 32.0°C 下 120 小时。

主要结果和测量

主要结局为 18 至 22 个月时的死亡或残疾,目前正在进行中。在 50 名新生儿入组后,独立的数据和安全监测委员会为评估安全性(心律失常、持续性酸中毒、大血管血栓形成和出血、新生儿重症监护病房[NICU]内死亡)暂停了试验,随后每入组 25 名新生儿后再次评估。在第八次审查后,由于出现了新的安全性概况和无效性分析,有 364 名新生儿入组(计划入组 726 名)后,该试验被关闭。本报告重点关注安全性和 NICU 死亡率,通过 72 小时与 120 小时持续时间和 33.5°C 与 32.0°C 深度的边缘比较(预先定义的次要结局)。

结果

NICU 死亡率为:33.5°C 下 72 小时组为 95 名新生儿中的 7 名(7%)、32.0°C 下 72 小时组为 90 名新生儿中的 13 名(14%)、33.5°C 下 120 小时组为 96 名新生儿中的 15 名(16%)和 32.0°C 下 120 小时组为 83 名新生儿中的 14 名(17%)。120 小时组与 72 小时组相比,NICU 死亡的调整风险比(RR)为 1.37(95%CI,0.92-2.04),32.0°C 组与 33.5°C 组相比,RR 为 1.24(95%CI,0.69-2.25)。120 小时组与 72 小时组和 32.0°C 组与 33.5°C 组之间的安全性结果相似,除了 120 小时组中有 1%发生严重出血,而 72 小时组中有 3%(RR,0.25[95%CI,0.07-0.91])。无效性分析确定,检测到更长时间冷却、更深冷却或两者联合应用于 NICU 死亡的统计学显著益处的可能性小于 2%。

结论和相关性

对于患有中重度缺氧缺血性脑病的足月新生儿,与 33.5°C 下 72 小时的低温治疗相比,更长时间、更深的冷却或两者联合应用并未降低 NICU 死亡率。这些结果对患者护理和未来试验设计具有重要意义。

试验注册

clinicaltrials.gov 标识符:NCT01192776。

相似文献

1
Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial.深度和冷却持续时间对患有缺氧缺血性脑病的新生儿重症监护病房死亡率的影响:一项随机临床试验。
JAMA. 2014;312(24):2629-39. doi: 10.1001/jama.2014.16058.
2
Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.低温治疗的深度和持续时间对缺氧缺血性脑病新生儿18个月时死亡或致残的影响:一项随机临床试验。
JAMA. 2017 Jul 4;318(1):57-67. doi: 10.1001/jama.2017.7218.
3
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study.在新生儿缺氧缺血性脑病低温治疗后复温期间癫痫发作增加与 2 年随访时神经发育不良结局的相关性:一项嵌套多中心队列研究。
JAMA Neurol. 2021 Dec 1;78(12):1484-1493. doi: 10.1001/jamaneurol.2021.3723.
4
Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.6小时龄后开始治疗性低温对缺氧缺血性脑病新生儿死亡或残疾的影响:一项随机临床试验
JAMA. 2017 Oct 24;318(16):1550-1560. doi: 10.1001/jama.2017.14972.
5
Temperature profile and outcomes of neonates undergoing whole body hypothermia for neonatal hypoxic-ischemic encephalopathy.新生儿缺氧缺血性脑病全身低温治疗的体温曲线和结局。
Pediatr Crit Care Med. 2012 Jan;13(1):53-9. doi: 10.1097/PCC.0b013e31821926bc.
6
Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical Trial.全身低温治疗、脑磁共振生物标志物与在三级医疗中心与其他医疗机构出生的中重度缺氧缺血性脑病新生儿的结局:一项随机临床试验的嵌套研究。
JAMA Netw Open. 2023 May 1;6(5):e2312152. doi: 10.1001/jamanetworkopen.2023.12152.
7
Limitations of Conventional Magnetic Resonance Imaging as a Predictor of Death or Disability Following Neonatal Hypoxic-Ischemic Encephalopathy in the Late Hypothermia Trial.常规磁共振成像作为预测新生儿缺氧缺血性脑病低温治疗后死亡或残疾的局限性:晚期低温治疗试验。
J Pediatr. 2021 Mar;230:106-111.e6. doi: 10.1016/j.jpeds.2020.11.015. Epub 2020 Nov 13.
8
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.新生儿缺氧缺血性脑病的全身低温治疗
N Engl J Med. 2005 Oct 13;353(15):1574-84. doi: 10.1056/NEJMcps050929.
9
Cooling for newborns with hypoxic ischaemic encephalopathy.对患有缺氧缺血性脑病的新生儿进行降温治疗。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003311. doi: 10.1002/14651858.CD003311.pub3.
10
Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial.对足月和近足月缺氧缺血性脑病新生儿进行全身低温治疗:一项随机对照试验。
Arch Pediatr Adolesc Med. 2011 Aug;165(8):692-700. doi: 10.1001/archpediatrics.2011.43. Epub 2011 Apr 4.

引用本文的文献

1
Single-Cell Transcriptomic Profiling of Brain Cells in Newborn Rats Following Hypoxic Ischemic Encephalopathy.缺氧缺血性脑病后新生大鼠脑细胞的单细胞转录组分析
FASEB J. 2025 Aug 31;39(16):e70929. doi: 10.1096/fj.202402891RR.
2
Role of Netrin-1 in staging hypoxic ischemic encephalopathy.Netrin-1在缺氧缺血性脑病分期中的作用。
Rev Assoc Med Bras (1992). 2025 Jun 16;71(5):e20241889. doi: 10.1590/1806-9282.20241889. eCollection 2025.
3
Translational Potential of Stem Cell-based Therapies in the Treatment of Neonatal Hypoxic-ischemic Brain Injury.

本文引用的文献

1
Effects of hypothermia for perinatal asphyxia on childhood outcomes.围产期窒息后低温对儿童结局的影响。
N Engl J Med. 2014 Jul 10;371(2):140-9. doi: 10.1056/NEJMoa1315788.
2
Hypothermia and neonatal encephalopathy.低体温与新生儿脑病。
Pediatrics. 2014 Jun;133(6):1146-50. doi: 10.1542/peds.2014-0899.
3
Elevated temperature and 6- to 7-year outcome of neonatal encephalopathy.新生儿脑病的高温和 6 至 7 年的结果。
基于干细胞的疗法在治疗新生儿缺氧缺血性脑损伤中的转化潜力
Stem Cell Rev Rep. 2025 Jun 5. doi: 10.1007/s12015-025-10905-9.
4
Therapeutic hypothermia for neonates: a bibliometric analysis and visualization research.新生儿治疗性低温:文献计量分析与可视化研究
Front Neurol. 2025 May 7;16:1565749. doi: 10.3389/fneur.2025.1565749. eCollection 2025.
5
Ongoing loss of viable neurons for weeks after mild hypoxia-ischaemia.轻度缺氧缺血后数周内,存活神经元持续丢失。
Brain Commun. 2025 Apr 18;7(2):fcaf153. doi: 10.1093/braincomms/fcaf153. eCollection 2025.
6
Single-center analysis of servo-controlled cooling during the transport of neonates with perinatal asphyxia.围产期窒息新生儿转运期间伺服控制冷却的单中心分析
Front Pediatr. 2025 Mar 20;13:1562736. doi: 10.3389/fped.2025.1562736. eCollection 2025.
7
Prediction of Neurodevelopmental Outcomes at 18 to 22 Months Using the Numerical Sarnat Score Compared with Modified Sarnat Staging in Infants with Moderate to Severe Hypoxic-Ischemic Encephalopathy.使用数字Sarnat评分与改良Sarnat分期对中度至重度缺氧缺血性脑病婴儿18至22个月时神经发育结局的预测
J Pediatr. 2025 Jun;281:114522. doi: 10.1016/j.jpeds.2025.114522. Epub 2025 Feb 21.
8
NICHD Magnetic Resonance Brain Imaging Score in Term Infants With Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of a Randomized Clinical Trial.患有缺氧缺血性脑病的足月儿的美国国立儿童健康与人类发展研究所磁共振脑成像评分:一项随机临床试验的二次分析
JAMA Pediatr. 2025 Apr 1;179(4):383-395. doi: 10.1001/jamapediatrics.2024.6209.
9
Redirection of Care for Neonates with Hypoxic-Ischemic Encephalopathy Receiving Therapeutic Hypothermia.对接受治疗性低温治疗的缺氧缺血性脑病新生儿的护理调整
J Clin Med. 2025 Jan 7;14(2):317. doi: 10.3390/jcm14020317.
10
The Role of Proton Magnetic Resonance Spectroscopy in Neonatal and Fetal Brain Research.质子磁共振波谱在新生儿和胎儿脑研究中的作用
J Magn Reson Imaging. 2025 Jun;61(6):2404-2424. doi: 10.1002/jmri.29709. Epub 2025 Jan 21.
Ann Neurol. 2013 Apr;73(4):520-8. doi: 10.1002/ana.23843. Epub 2013 Apr 17.
4
Cooling for newborns with hypoxic ischaemic encephalopathy.对患有缺氧缺血性脑病的新生儿进行降温治疗。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003311. doi: 10.1002/14651858.CD003311.pub3.
5
Recooling for rebound seizures after rewarming in neonatal encephalopathy.新生儿脑病复温后再发性惊厥的复温。
Pediatrics. 2012 Aug;130(2):e451-5. doi: 10.1542/peds.2011-3496. Epub 2012 Jul 2.
6
Childhood outcomes after hypothermia for neonatal encephalopathy.新生儿脑病低温治疗后的儿童结局。
N Engl J Med. 2012 May 31;366(22):2085-92. doi: 10.1056/NEJMoa1112066.
7
Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis.新生儿缺氧缺血性脑病的低温治疗:一项更新的系统评价和荟萃分析。
Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):558-66. doi: 10.1001/archpediatrics.2011.1772.
8
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy.新生儿脑病头部冷却的 CoolCap 试验的 7 至 8 年随访。
Pediatr Res. 2012 Feb;71(2):205-9. doi: 10.1038/pr.2011.30. Epub 2011 Dec 21.
9
Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial.对足月和近足月缺氧缺血性脑病新生儿进行全身低温治疗:一项随机对照试验。
Arch Pediatr Adolesc Med. 2011 Aug;165(8):692-700. doi: 10.1001/archpediatrics.2011.43. Epub 2011 Apr 4.
10
Treatment advances in neonatal neuroprotection and neurointensive care.新生儿神经保护和神经重症监护的治疗进展。
Lancet Neurol. 2011 Apr;10(4):372-82. doi: 10.1016/S1474-4422(11)70016-3.